Primo Partners with SHINE to Advance Precision Cancer Care in Asia-Pacific
08. Januar 2025 20:00 ET
|
Primo Biotechnology Co., Ltd.
Primo partners with SHINE to bring Ilumira to Asia-Pacific, advancing radioligand therapy and precision cancer care with exclusive rights in key markets.